Pierre Raboisson
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- Biochemical and Molecular Research 5
- Phosphodiesterase function and regulation 5
- Hepatology 22
- Hepatitis C virus research 22
- Co-authors
- Maxwell D. Cummings (13 shared papers)Oliver Lenz (10 shared papers)Herman de Kock (8 shared papers)Kenneth Simmen (13 shared papers)Tse‐I Lin (12 shared papers)Bertil Samuelsson (8 shared papers)Åsa Rosenquist (8 shared papers)Anthony Baurand (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Antimicrobial Agents and Chemotherapy (6 papers)European Journal of Medicinal Chemistry (4 papers)Tetrahedron Letters (4 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Pierre Raboisson
58 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 85
- Hepatology 636
- Infectious Diseases 497
- Physiology 111
- Organic Chemistry 555
- Epidemiology 534
Countries citing papers authored by Pierre Raboisson
This map shows the geographic impact of Pierre Raboisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Raboisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Raboisson more than expected).
Fields of papers citing papers by Pierre Raboisson
This network shows the impact of papers produced by Pierre Raboisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Raboisson. The network helps show where Pierre Raboisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Raboisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 178 | |
| 2 | 2014 | 158 | |
| 3 | 2009 | 142 | |
| 4 | 2006 | 131 | |
| 5 | 2001 | 128 | |
| 6 | 2010 | 71 | |
| 7 | 2006 | 57 | |
| 8 | 2007 | 55 | |
| 9 | 2020 | 55 | |
| 10 | 2009 | 50 | |
| 11 | 2006 | 49 | |
| 12 | 1997 | 44 | |
| 13 | 2002 | 42 | |
| 14 | 2018 | 42 | |
| 15 | 2005 | 41 | |
| 16 | 2021 | 39 | |
| 17 | 2008 | 37 | |
| 18 | 2003 | 34 | |
| 19 | 1997 | 34 | |
| 20 | 2013 | 33 |
About Pierre Raboisson
Pierre Raboisson is a scholar working on Molecular Biology, Hepatology, Infectious Diseases, Organic Chemistry and Epidemiology, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (13 papers), HIV/AIDS drug development and treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers), Cancer-related Molecular Pathways (5 papers), Biochemical and Molecular Research (5 papers) and Phosphodiesterase function and regulation (5 papers). The work is most often cited by research in Hepatology (636 citations), Infectious Diseases (497 citations), Physiology (111 citations), Organic Chemistry (555 citations) and Epidemiology (534 citations). Pierre Raboisson has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Maxwell D. Cummings, Oliver Lenz, Herman de Kock, Kenneth Simmen, Tse‐I Lin, Bertil Samuelsson, Åsa Rosenquist, Anthony Baurand, Jan Martin Berke and Jean‐Pierre Cazenave. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, European Journal of Medicinal Chemistry and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.